Cargando…

Natural Compounds as Therapeutic Agents in the Treatment Cystic Fibrosis

The recent FDA approval of two drugs to treat the basic defect in cystic fibrosis has given hope to patients and their families battling this devastating disease. Over many years, with heavy financial investment from Vertex Pharmaceuticals and the Cystic Fibrosis Foundation, pre-clinical evaluation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dey, Isha, Shah, Kalpit, Bradbury, Neil A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828912/ https://www.ncbi.nlm.nih.gov/pubmed/27081574 http://dx.doi.org/10.4172/2157-7412.1000284

Ejemplares similares

Lemur Tyrosine Kinase 2, a novel target in prostate cancer therapy
por: Shah, Kalpit, et al.
Publicado: (2015)

Activation of TPA-response element present in human Lemur Tyrosine Kinase 2 (lmtk2) gene increases its expression
por: Dey, Isha, et al.
Publicado: (2017)

Cysteamine (Lynovex®), a novel mucoactive antimicrobial & antibiofilm agent for the treatment of cystic fibrosis
por: Charrier, Cedric, et al.
Publicado: (2014)

Natural Health Products (NHP’s) and Natural Compounds as Therapeutic Agents for the Treatment of Cancer; Mechanisms of Anti-Cancer Activity of Natural Compounds and Overall Trends
por: Scaria, Benjamin, et al.
Publicado: (2020)

Natural Compounds as Therapeutic Agents: The Case of Human Topoisomerase IB
por: Ottaviani, Alessio, et al.
Publicado: (2021)

3425 Cardiac Replacement Fibrosis in Cancer Treatment Related Cardiotoxicity
por: Shenoy, Chetan, et al.
Publicado: (2019)

Antiproteases as Therapeutics to Target Inflammation in Cystic Fibrosis
por: Quinn, Derek J, et al.
Publicado: (2010)

Inhaled therapy in cystic fibrosis: agents, devices and regimens
por: Agent, Penny, et al.
Publicado: (2015)

Drug treatment of cystic fibrosis
por: Bruorton, Matthew, et al.
Publicado: (2022)

Cell-Based Therapeutic Approaches for Cystic Fibrosis
por: Duchesneau, Pascal, et al.
Publicado: (2020)

Editorial: Emerging Therapeutic Approaches for Cystic Fibrosis
por: Lopes-Pacheco, Miquéias, et al.
Publicado: (2019)

Preclinical Modeling for Therapeutic Development in Cystic Fibrosis
por: Bonfield, Tracey L.
Publicado: (2020)

Synthesis and Therapeutic Applications of Iminosugars in Cystic Fibrosis
por: Esposito, Anna, et al.
Publicado: (2020)

Novel therapeutic approaches for the management of cystic fibrosis
por: Jaques, Ryan, et al.
Publicado: (2020)

Cystic Fibrosis: “Ionocyte Modulators”?
por: Shah, Viral S., et al.
Publicado: (2023)

Variable Susceptibility to Gallium Compounds of Major Cystic Fibrosis Pathogens
por: Visaggio, Daniela, et al.
Publicado: (2021)

Natural Sulfur-Containing Compounds: An Alternative Therapeutic Strategy against Liver Fibrosis
por: Milito, Alfonsina, et al.
Publicado: (2019)

Cystic Fibrosis–Related Diabetes: Pathophysiology and Therapeutic Challenges
por: Kelsey, Ryan, et al.
Publicado: (2019)

Natural Compounds as Promising Adjuvant Agents in The Treatment of Gliomas
por: Persano, Francesca, et al.
Publicado: (2022)

Natural Compounds as Antimicrobial Agents
por: Franco, Carlos Manuel, et al.
Publicado: (2020)

The treatment burden of cystic fibrosis: a day-to-day experience with treatment as someone with cystic fibrosis
por: Maetz, Jessica, et al.
Publicado: (2021)

Progress in the pharmacological treatment of human cystic and alveolar echinococcosis: Compounds and therapeutic targets
por: Siles-Lucas, Mar, et al.
Publicado: (2018)

Emerging microRNA Therapeutic Approaches for Cystic Fibrosis
por: Bardin, Pauline, et al.
Publicado: (2018)

Cystic fibrosis: current therapeutic targets and future approaches
por: Rafeeq, Misbahuddin M., et al.
Publicado: (2017)

Editorial: Special Issue on “Therapeutic Approaches for Cystic Fibrosis”
por: Pedemonte, Nicoletta
Publicado: (2020)

Natural Compounds in Sex Hormone-Dependent Cancers: The Role of Triterpenes as Therapeutic Agents
por: Şoica, Codruţa, et al.
Publicado: (2021)

Inhaled Biologicals for the Treatment of Cystic Fibrosis
por: Sala, Valentina, et al.
Publicado: (2019)

Cystic Fibrosis
por: Dodge, J A
Publicado: (1997)

Primary lung carcinoma in cystic fibrosis: A case report and literature review
por: Patel, Vipul, et al.
Publicado: (2020)

Case report of compound CFTR variants in Korean siblings with cystic fibrosis: importance of differentiating cystic fibrosis from inflammatory bowel disease
por: Park, Hyejin, et al.
Publicado: (2021)

Antimicrobial Properties of Mesenchymal Stem Cells: Therapeutic Potential for Cystic Fibrosis Infection, and Treatment
por: Sutton, Morgan T., et al.
Publicado: (2016)

TMEM16A Potentiation: A Novel Therapeutic Approach for the Treatment of Cystic Fibrosis
por: Danahay, Henry L., et al.
Publicado: (2020)

Human Nasal Epithelial Organoids for Therapeutic Development in Cystic Fibrosis
por: Liu, Zhongyu, et al.
Publicado: (2020)

Furin as a therapeutic target in cystic fibrosis airways disease
por: Douglas, Lisa E.J., et al.
Publicado: (2023)

Chronic rhinosinusitis in cystic fibrosis: a review of therapeutic options
por: Krajewska, Joanna, et al.
Publicado: (2021)

Gene therapy for the treatment of cystic fibrosis
por: Burney, Tabinda J, et al.
Publicado: (2012)

Cystic Fibrosis
por: Gibson, Lewis E.
Publicado: (1969)

Infections in cystic fibrosis
por: Marks-Austin, Kathy A., et al.
Publicado: (1995)

Metabolomics of pulmonary exacerbations reveals the personalized nature of cystic fibrosis disease
por: Quinn, Robert A., et al.
Publicado: (2016)

Molecular targets for cystic fibrosis and therapeutic potential of monoclonal antibodies
por: Moni, Sivakumar S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c2ggus5c3sujsn3f8ha4floe46